我们的生活和困难时期.

Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.

Eye (London, England)·2010

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.

Statistics in medicine·2009

Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease.

Journal of thrombosis and haemostasis : JTH·2008

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.

European journal of epidemiology·2007

Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).

Journal of thrombosis and haemostasis : JTH·2006

Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.

Journal of thrombosis and haemostasis : JTH·2006

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Discrepancies between instant and filtered coffee in biological aging: evidence from the UK Biobank.

NPJ science of food·2026

Local ancestry inference with poorly-matched reference panels.

PLoS genetics·2026

Clinical and Molecular Features of <i>CNGA1</i>-Associated Retinitis Pigmentosa in an East Asian Cohort: Insights for Gene Therapy Trials.

Ophthalmology science·2026

Oral health-related quality of life and active aging in Korean older adults: A longitudinal panel study with marginal structural model sensitivity analyses.

Archives of gerontology and geriatrics·2026

Characteristics of fall recurrence among persistent, quasi-persistent, and transient fallers: a 3-year analysis from the SCOPE study.

European geriatric medicine·2026

GeNED.ar cohort: Neuroimaging Resource for Aging Studies in an Admixed Population from Argentina.

NeuroImage·2026

相关实验视频

我们的生活和困难时期.

相关概念视频

Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.

Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease.

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.

Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).

Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Discrepancies between instant and filtered coffee in biological aging: evidence from the UK Biobank.

Local ancestry inference with poorly-matched reference panels.

Clinical and Molecular Features of <i>CNGA1</i>-Associated Retinitis Pigmentosa in an East Asian Cohort: Insights for Gene Therapy Trials.

Oral health-related quality of life and active aging in Korean older adults: A longitudinal panel study with marginal structural model sensitivity analyses.

Characteristics of fall recurrence among persistent, quasi-persistent, and transient fallers: a 3-year analysis from the SCOPE study.

GeNED.ar cohort: Neuroimaging Resource for Aging Studies in an Admixed Population from Argentina.

相关实验视频

我们的生活和困难时期.

相关概念视频

相关文章